Literature DB >> 12768860

National survey on cholecystectomy related bile duct injury--public health and financial aspects in Belgian hospitals--1997.

St Van de Sande1, M Bossens, Y Parmentier, J F Gigot.   

Abstract

Public health and financial aspects of cholecystectomy related bile duct injury (BDI) are highlighted in a National Cholecystectomy Survey carried out through 'datamining' the Federal State Medical Records Summaries and Financial Summaries of all Belgian hospitals in 1997. All cancer diagnoses, children < or = 10 years, cholecystectomies performed as an abdominal co-procedure or patients having undergone other non-related surgery were excluded from the study. 10.595 laparoscopic (LC) and 1.033 open cholecystectomies (OC) as well as 137 secondary BDI treatments (LC/OC) were included in the survey (total 11.765). Both LC and OC groups turned out to be significantly different as to distribution of patient's age and APR-DRG severity classes. Composite criteria in terms of ICD-9-CM and billing codes were elaborated to classify: 1) primary, intra-operatively detected and treated BDI (N = 30), 2) primary delayed BDI treatments (N = 38), 3) secondary BDI treatments (N = 137), 4) non-BDI abdomino-surgical complications (N = 119), 4) uneventful laparoscopic (N = 7.476) and 5) uneventful open cholecystectomy (N = 681). Complication rates, community costs of LC and OC groups, incidence of preoperative ERCP and/or intra-operative cholangiography as well as interventions for complications were studied. Incidence of cholecystectomy related BDI was 0.37% in LC, 2.81% in OC and 0.58% overall. Average costs amounted to [symbol: see text] 1.721 for uneventful LC, [symbol: see text] 2.924 for uneventful OC, [symbol: see text] 7.250 for primary, intra-operatively detected and immediately treated BDI [symbol: see text] 9.258 for primary delayed BDI treatments, [symbol: see text] 6.076 for secondary BDI treatments and [symbol: see text] 10.363 for non-BDI abdomino-surgical complications. In conclusion BDI with cholecystectomy reveals to be a serious complication increasing the overall average cost factor ninefold if not detected intra-operatively, in which case the raise is only fourfold. As a consequence BDI should be avoided by all means. In this respect 4 crucial surgical guidelines are emphasised.

Entities:  

Mesh:

Year:  2003        PMID: 12768860     DOI: 10.1080/00015458.2003.11679403

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  12 in total

1.  The epistemology of evidence-based medicine.

Authors:  L A Michel
Journal:  Surg Endosc       Date:  2007-02       Impact factor: 4.584

2.  Intraoperative cholangiography using an endoscopic nasobiliary tube during a laparoscopic cholecystectomy.

Authors:  Tetsuo Ikeda; Yusuke Yonemura; Naoyuki Ueda; Akira Kabashima; Kohjiro Mashino; Kizuku Yamashita; Kyuzo Fujii; Hideya Tashiro; Hisanobu Sakata
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

3.  Medicolegal costs of bile duct injuries incurred during laparoscopic cholecystectomy.

Authors:  Pankaj G Roy; Zahir F Soonawalla; Hugh W Grant
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

4.  How often do surgeons obtain the critical view of safety during laparoscopic cholecystectomy?

Authors:  Dimitrios Stefanidis; Nikita Chintalapudi; Brittany Anderson-Montoya; Bindhu Oommen; Daniel Tobben; Manuel Pimentel
Journal:  Surg Endosc       Date:  2016-05-03       Impact factor: 4.584

5.  Effect of tamoxifen on fibrosis, collagen content and transforming growth factor-β1, -β2 and -β3 expression in common bile duct anastomosis of pigs.

Authors:  Orlando Hiroshi Kiono Siqueira; Karen Jesus Oliveira; Angela Cristina Gouvêa Carvalho; Antonio Claudio Lucas da Nóbrega; Renata Frauches Medeiros; Bruno Felix-Patrício; Fábio Otero Áscoli; Beni Olej
Journal:  Int J Exp Pathol       Date:  2017-12-04       Impact factor: 1.925

6.  Registering the critical view of safety: photo or video?

Authors:  M Emous; M Westerterp; J Wind; J P Eerenberg; A A W van Geloven
Journal:  Surg Endosc       Date:  2010-04-08       Impact factor: 4.584

7.  Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents.

Authors:  Aya Matsui; Eiichi Tanaka; Hak Soo Choi; Joshua H Winer; Vida Kianzad; Sylvain Gioux; Rita G Laurence; John V Frangioni
Journal:  Surgery       Date:  2010-02-01       Impact factor: 3.982

Review 8.  Long-Term Impact of Iatrogenic Bile Duct Injury.

Authors:  Anne Marthe Schreuder; Olivier R Busch; Marc G Besselink; Povilas Ignatavicius; Antanas Gulbinas; Giedrius Barauskas; Dirk J Gouma; Thomas M van Gulik
Journal:  Dig Surg       Date:  2019-01-17       Impact factor: 2.588

9.  Tamoxifen decreases the myofibroblast count in the healing bile duct tissue of pigs.

Authors:  Orlando Hiroshi Kiono Siqueira; Benedito Herani Filho; Rafael Erthal de Paula; Fábio Otero Ascoli; Antonio Cláudio Lucas da Nóbrega; Angela Cristina Gouvêa Carvalho; Andréa Rodrigues Cordovil Pires; Nicolle Cavalcante Gaglionone; Karin Soares Gonçalves Cunha; José Mauro Granjeiro
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

Review 10.  Optimal timing for surgical reconstruction of bile duct injury: meta-analysis.

Authors:  A M Schreuder; B C Nunez Vas; K A C Booij; S van Dieren; M G Besselink; O R Busch; T M van Gulik
Journal:  BJS Open       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.